Sponsor Dossier
Viatris
Sponsor Dossier for Viatris. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ACNATAC
- Brand: AERON
- Brand: AMIRA
- Brand: ANPEC
- Brand: ASPALGIN
- Brand: ASPECILLIN VK
- Brand: AURORIX
- Brand: BECONASE
- Device (sponsor): Lubricant, eye
- Device (sponsor): Oral/enteral medicine medicated administration kit, reusable
- Device (sponsor): Spoon, medicine, reusable
About
Viatris is an Australian Private Company with ABN 29601608771, registered in NSW and currently active. The company was previously known as Mylan Health and Mylan EPD before adopting the Viatris name in 2021.
Portfolio
Viatris has 78 brands on the ARTG, of which 66 are indexable. Sixty-five brands have Product Information on file. Twenty-six brands are PBS-listed, 9 brands have PBAC outcomes on record, and 7 brands have AusPARs on record.
Therapeutic focus —
Cardiology: 21 brands — Neurology: 16 brands — Infectious Disease: 9 brands — Ophthalmology: 7 brands — Gastroenterology: 7 brands — Pain & Anaesthesia: 4 brands — Oncology: 4 brands — Immunology: 3 brands — Urology: 2 brands — Respiratory: 2 brands — Dermatology: 2 brands — Pain Management: 1 brand
PBS footprint
Twenty-six of Viatris's brands are PBS-listed, with the portfolio most recently touching the PBS schedule on 1 May 2026.
Regulatory activity
Viatris's latest PBAC outcome was recorded on 1 December 2025, with 9 brands holding PBAC outcomes on record. The most recent AusPAR dates to 1 November 2017, with 7 brands holding AusPARs on record.